Macrogenics(MGNX)

Biopharmaceutical company

1 Insight

Investment Insights

AI-generated insights about Macrogenics from various financial sources

Friday, August 22, 2025

Very Bullish

A director made a significant insider purchase of $150,000 after a 50% stock drop, which is the first in over a year. The director's last purchase was followed by a 100% stock increase.